Pharming Group N.V. (PHAR)
NASDAQ: PHAR · Real-Time Price · USD
12.95
+0.33 (2.59%)
May 12, 2026, 11:26 AM EDT - Market open

Pharming Group Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
May '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
9201,240685767724580
Market Cap Growth
52.87%80.98%-10.69%5.95%24.82%-40.25%
Enterprise Value
865.321,168622.3719.72678.07545.52
Last Close Price
12.9517.6710.0711.4311.038.94
PE Ratio
74.49441.75-55.94-71.4458.0538.87
PS Ratio
2.493.302.313.133.522.92
PB Ratio
3.424.473.103.513.543.01
P/TBV Ratio
3.604.763.583.793.813.25
P/FCF Ratio
16.5222.98-265.02-40.9334.3421.40
P/OCF Ratio
16.3122.66-381.65-44.3332.2415.33
EV/Sales Ratio
2.343.102.092.933.302.74
EV/EBITDA Ratio
20.4731.5183.5468.3021.5816.45
EV/EBIT Ratio
24.8045.19-72.18-133.6037.1940.23
EV/FCF Ratio
15.5321.64-240.73-38.4132.1620.13
Debt / Equity Ratio
0.400.390.480.760.790.82
Debt / EBITDA Ratio
2.933.1215.0816.285.314.88
Debt / FCF Ratio
2.092.15-43.45-9.157.915.97
Net Debt / Equity Ratio
-0.20-0.23-0.25-0.19-0.20-0.16
Net Debt / EBITDA Ratio
-1.36-1.71-7.46-3.97-1.29-0.91
Net Debt / FCF Ratio
-0.97-1.1721.502.24-1.93-1.11
Asset Turnover
0.750.840.690.550.500.49
Inventory Turnover
0.680.750.630.510.500.87
Quick Ratio
2.052.023.023.333.944.74
Current Ratio
2.632.593.774.064.655.33
Return on Equity (ROE)
4.46%4.22%-6.13%-5.23%6.88%8.50%
Return on Assets (ROA)
7.83%5.74%-2.00%-1.21%4.82%3.32%
Return on Invested Capital (ROIC)
17.98%13.59%-5.04%-3.16%12.13%8.26%
Return on Capital Employed (ROCE)
7.33%7.28%-2.42%-1.43%5.09%3.92%
Earnings Yield
1.34%0.23%-1.79%-1.40%1.72%2.57%
FCF Yield
6.05%4.35%-0.38%-2.44%2.91%4.67%
Buyback Yield / Dilution
-13.48%4.91%-8.26%-2.59%-0.85%-2.70%
Total Shareholder Return
-13.48%4.91%-8.26%-2.59%-0.85%-2.70%
Updated May 7, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q